IDEAYA Biosciences and Boston Childrens Hospital Collaborate on Preclinical Evaluation of IDE196 for Sturge Weber Syndrome a Rare Disease Associated with Genetic Mutation of GNAQ
Friday, January 10, 2020 1 min read
Key Takeaway: IDEAYA Biosciences and Boston Childrens Hospital Collaborate on Preclinical Evaluation of IDE196 for Sturge Weber Syndrome a Rare Disease Associated with Genetic Mutation of GNAQ
Full Press Release Details
IDEAYA Biosciences and Boston Childrens Hospital Collaborate on Preclinical Evaluation of IDE196 for Sturge Weber Syndrome a Rare Disease Associated with Genetic Mutation of GNAQ.